Pages that link to "Q59206238"
Jump to navigation
Jump to search
The following pages link to Hippocampal synaptic metaplasticity requires the activation of NR2B-containing NMDA receptors (Q59206238):
Displaying 10 items.
- Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity (Q26750576) (← links)
- GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects (Q30440925) (← links)
- Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase (Q30465622) (← links)
- PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13. (Q35224315) (← links)
- FRET-FLIM investigation of PSD95-NMDA receptor interaction in dendritic spines; control by calpain, CaMKII and Src family kinase (Q35417027) (← links)
- Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine via Regulating the Trafficking and Function of Spinal NMDA Receptors as well as PKC and CaMKII Level In Vivo and In Vitro (Q36275465) (← links)
- Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13). (Q37741989) (← links)
- Metaplasticity in human cortex (Q38195271) (← links)
- From the genetic architecture to synaptic plasticity in autism spectrum disorder (Q38569746) (← links)
- CaMKII Metaplasticity Drives Aβ Oligomer-Mediated Synaptotoxicity (Q57524986) (← links)